Is Insulet (PODD) Stock an Apt Pick for Your Portfolio Now? [Yahoo! Finance]
Insulet Corporation (PODD)
Last insulet corporation earnings: 2/25 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.insulet.com/investor-relations
Company Research
Source: Yahoo! Finance
The company is making remarkable progress in terms of its key strategic imperatives to help patients in their diabetes management. Sound financial stability further instills optimism. Meanwhile, the growing macroeconomic challenges raise concerns for Insulet's operations, which may hinder its growth prospects. The company's sole reliance on the Omnipod platform may become a risk if any adverse changes occur. In the past year, this Zacks Rank #3 (Hold) stock has declined 28.7% compared to the 2.9% rise of the industry and the 16.5% growth of the S&P 500 composite. The developer, manufacturer and distributor of insulin delivery systems has a market capitalization of $13.46 billion. Insulet projects a long-term estimated earnings growth rate of 17.9% compared with 11.9% of the industry. PODD's earnings surpassed estimates in each of the trailing four quarters, delivering an average surprise of 83%. Let's delve deeper. Upsides Omnipod 5, a New Focus: Insulet's highly different
Show less
Read more
Impact Snapshot
Event Time:
PODD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PODD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PODD alerts
High impacting Insulet Corporation news events
Weekly update
A roundup of the hottest topics
PODD
News
- ESLOY vs. PODD: Which Stock Is the Better Value Option? [Yahoo! Finance]Yahoo! Finance
- Insulet's (PODD) Omnipod 5 Favored in Study for Type 2 Diabetes [Yahoo! Finance]Yahoo! Finance
- Insulet plans label expansion for Omnipod in type 2 diabetes [Yahoo! Finance]Yahoo! Finance
- Insulet's SECURE-T2D Pivotal Trial Results Demonstrate Omnipod® 5 Improves Clinical Outcomes and Quality of Life in Type 2 Diabetes [Yahoo! Finance]Yahoo! Finance
- Insulet’s SECURE-T2D Pivotal Trial Results Demonstrate Omnipod® 5 Improves Clinical Outcomes and Quality of Life in Type 2 DiabetesBusiness Wire
PODD
Earnings
- 5/9/24 - Beat
PODD
Sec Filings
- 6/25/24 - Form 144
- 6/17/24 - Form 4
- 6/14/24 - Form 144
- PODD's page on the SEC website